Lista de obras -

A Presurgical Study of Lecithin Formulation of Green Tea Extract in Women with Early Breast Cancer

artículo científico publicado en 2017

A Presurgical Study of Oral Silybin-Phosphatidylcholine in Patients with Early Breast Cancer.

artículo científico publicado en 2015

A Randomized, Placebo-Controlled, Phase II, Presurgical Biomarker Trial of Celecoxib Versus Exemestane in Postmenopausal Breast Cancer Patients

artículo científico publicado en 2016

A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer

artículo científico publicado en 2006

A pooled analysis of CYP2D6 genotype in breast cancer prevention trials of low-dose tamoxifen

artículo científico publicado en 2016

A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer

artículo científico publicado en 2013

A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers

artículo científico publicado en 2004

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial

artículo científico publicado en 2013

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial

artículo científico publicado en 2015

Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials

artículo científico publicado en 2013

Benefit of low-dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS.

artículo científico publicado en 2016

Biologic Activity of Tamoxifen at Low Doses in Healthy Women

artículo científico publicado en 1998

Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences

artículo científico publicado en 2014

Breast cancer prevention trials using retinoids

artículo científico publicado en 2003

Breast conservative surgery for well-differentiated ductal intraepithelial neoplasia: Risk factors for ipsilateral breast tumor recurrence.

artículo científico publicado en 2014

Breast ductal lavage for biomarker assessment in high risk women: rationale, design and methodology of a randomized phase II clinical trial with nimesulide, simvastatin and placebo

artículo científico publicado en 2012

Budesonide versus placebo in high-risk population with screen-detected lung nodules: rationale, design and methodology

artículo científico publicado en 2010

Chemoprevention of breast cancer: the Italian experience.

artículo científico publicado en 2000

Chemoprevention studies within lung cancer screening programmes

artículo científico publicado en 2015

Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis

artículo científico publicado en 2014

Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide.

artículo científico publicado en 2013

Computer-assisted image analysis of breast fine needle aspiration in a randomized chemoprevention trial of fenretinide vs. placebo in HRT users.

artículo científico publicado en 2007

Correlation between tamoxifen elimination and biomarker recovery in a primary prevention trial.

artículo científico publicado en 2001

Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial.

artículo científico publicado en 2014

Difficult choices for young patients with cancer: the supportive role of decisional counseling.

artículo científico publicado en 2015

Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial

artículo científico publicado en 2012

Ductal intraepithelial neoplasia: postsurgical outcome for 1,267 women cared for in one single institution over 10 years

artículo científico publicado en 2009

Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical Trial

artículo científico publicado en 2015

Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction in healthy women

Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancer.

artículo científico publicado en 2008

Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women

artículo científico publicado en 2001

Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort study

artículo científico publicado en 2013

Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue.

artículo científico publicado en 2010

Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer

artículo científico publicado en 2001

Effect of tamoxifen at low doses on ultrasensitive C-reactive protein in healthy women.

artículo científico publicado en 2003

Effect of tamoxifen on lipoprotein(a) and insulin-like growth factor-I (IGF-I) in healthy women

artículo científico publicado en 1999

Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women.

artículo científico publicado en 2002

Effects of raloxifene on sex steroid hormones and C-telopeptide in postmenopausal women with primary breast cancer

artículo científico publicado en 2006

Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial

artículo científico publicado en 2010

Estrogen receptor in breast ductal carcinoma in situ: good cop, bad cop?

artículo científico

Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer

scientific article published on 01 November 2004

Fenretinide (4-HPR): a preventive chance for women at genetic and familial risk?

artículo científico publicado en 2012

Hormonal Therapy and Chemoprevention

scientific article published on 01 October 2000

Is it time to test metformin in breast cancer clinical trials?

artículo científico publicado en 2009

Lapatinib activity in premalignant lesions and HER-2-positive cancer of the breast in a randomized, placebo-controlled presurgical trial

artículo científico publicado en 2011

Long-term effects of fenretinide, a retinoic acid derivative, on the insulin-like growth factor system in women with early breast cancer

artículo científico publicado en 2001

Long-term effects of inhaled budesonide on screening-detected lung nodules.

artículo científico publicado en 2015

Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational study.

artículo científico publicado en 2009

Metformin and breast cancer risk.

artículo científico publicado en 2013

Ocular effects of fenretinide, a vitamin A analog, in a chemoprevention trial of bladder cancer

scientific article published on 01 January 2000

Pharmacological prevention of breast cancer: quo vadis?

artículo científico publicado en 2003

Preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal women.

artículo científico publicado en 2006

Prevention of breast cancer: focus on chemoprevention.

artículo científico publicado en 1998

Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer.

artículo científico publicado en 2011

Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer.

artículo científico publicado en 2010

QUALITY OF LIFE IN A RANDOMIZED BREAST CANCER PREVENTION TRIAL OF LOW-DOSE TAMOXIFEN AND FENRETINIDE IN PREMENOPAUSAL WOMEN

artículo científico publicado en 2018

Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT.

artículo científico publicado en 2006

Randomized biomarker trial of anastrozole or low-dose tamoxifen or their combination in subjects with breast intraepithelial neoplasia

artículo científico publicado en 2009

Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users

artículo científico publicado en 2007

Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.

artículo científico publicado en 2009

Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodules

artículo científico publicado en 2010

Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women

scientific article published on 28 April 2007

Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ.

artículo científico publicado en 2015

Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype

artículo científico publicado en 2013

Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial.

artículo científico publicado en 2004

The Italian breast cancer prevention trial with tamoxifen: findings and new perspectives

artículo científico publicado en 2001

The effect of metformin on apoptosis in a breast cancer presurgical trial.

artículo científico publicado en 2013

The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trial

artículo científico publicado en 2008

The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast.

artículo científico publicado en 2017

Tissue distribution of 4-hydroxy-N-desmethyltamoxifen and tamoxifen-N-oxide

artículo científico publicado en 2012

Update on tamoxifen to prevent breast cancer. The Italian Tamoxifen Prevention Study

artículo científico publicado en 2000

Vitamin D and overall mortality

artículo científico publicado en 2012

Worry and risk perception of breast cancer in a prevention trial of low dose tamoxifen in midlife postmenopausal hormone users

artículo científico publicado en 2017

Lista de obras de

A Presurgical Study of Lecithin Formulation of Green Tea Extract in Women with Early Breast Cancer

A Presurgical Study of Oral Silybin-Phosphatidylcholine in Patients with Early Breast Cancer.

A Randomized, Placebo-Controlled, Phase II, Presurgical Biomarker Trial of Celecoxib Versus Exemestane in Postmenopausal Breast Cancer Patients

A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer

A pooled analysis of CYP2D6 genotype in breast cancer prevention trials of low-dose tamoxifen

A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer

A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial

Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials

Benefit of low-dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS.

Biologic Activity of Tamoxifen at Low Doses in Healthy Women

Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences

Breast cancer prevention trials using retinoids

Breast conservative surgery for well-differentiated ductal intraepithelial neoplasia: Risk factors for ipsilateral breast tumor recurrence.

Breast ductal lavage for biomarker assessment in high risk women: rationale, design and methodology of a randomized phase II clinical trial with nimesulide, simvastatin and placebo

Budesonide versus placebo in high-risk population with screen-detected lung nodules: rationale, design and methodology

Chemoprevention of breast cancer: the Italian experience.

Chemoprevention studies within lung cancer screening programmes

Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis

Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide.

Computer-assisted image analysis of breast fine needle aspiration in a randomized chemoprevention trial of fenretinide vs. placebo in HRT users.

Correlation between tamoxifen elimination and biomarker recovery in a primary prevention trial.

Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial.

Difficult choices for young patients with cancer: the supportive role of decisional counseling.

Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial

Ductal intraepithelial neoplasia: postsurgical outcome for 1,267 women cared for in one single institution over 10 years

Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical Trial

Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction in healthy women

Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancer.

Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women

Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort study

Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue.

Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer

Effect of tamoxifen at low doses on ultrasensitive C-reactive protein in healthy women.

Effect of tamoxifen on lipoprotein(a) and insulin-like growth factor-I (IGF-I) in healthy women

Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women.

Effects of raloxifene on sex steroid hormones and C-telopeptide in postmenopausal women with primary breast cancer

Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial

Estrogen receptor in breast ductal carcinoma in situ: good cop, bad cop?

Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer

Fenretinide (4-HPR): a preventive chance for women at genetic and familial risk?

Hormonal Therapy and Chemoprevention

Is it time to test metformin in breast cancer clinical trials?

Lapatinib activity in premalignant lesions and HER-2-positive cancer of the breast in a randomized, placebo-controlled presurgical trial

Long-term effects of fenretinide, a retinoic acid derivative, on the insulin-like growth factor system in women with early breast cancer

Long-term effects of inhaled budesonide on screening-detected lung nodules.

Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational study.

Metformin and breast cancer risk.

Ocular effects of fenretinide, a vitamin A analog, in a chemoprevention trial of bladder cancer

Pharmacological prevention of breast cancer: quo vadis?

Preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal women.

Prevention of breast cancer: focus on chemoprevention.

Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer.

Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer.

QUALITY OF LIFE IN A RANDOMIZED BREAST CANCER PREVENTION TRIAL OF LOW-DOSE TAMOXIFEN AND FENRETINIDE IN PREMENOPAUSAL WOMEN

Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT.

Randomized biomarker trial of anastrozole or low-dose tamoxifen or their combination in subjects with breast intraepithelial neoplasia

Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users

Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.

Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodules

Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women

Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ.

Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype

Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial.

The Italian breast cancer prevention trial with tamoxifen: findings and new perspectives

The effect of metformin on apoptosis in a breast cancer presurgical trial.

The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trial

The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast.

Tissue distribution of 4-hydroxy-N-desmethyltamoxifen and tamoxifen-N-oxide

Update on tamoxifen to prevent breast cancer. The Italian Tamoxifen Prevention Study

Vitamin D and overall mortality

Worry and risk perception of breast cancer in a prevention trial of low dose tamoxifen in midlife postmenopausal hormone users